SCHEMBL16450484

SCHEMBL16450484

CNCC[C@H](NC)C(C)=O

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KISS1R Q969F8 3/20 0.42
HTR2A P28223 1/20 0.31
HRH1 P35367 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24728432 1.00 KISS1R (0.42) KISS1RHTR2AHRH1
SCHEMBL14525182 0.86 KISS1R (0.53) KISS1RHTR2AHRH1
SCHEMBL12890790 0.86 KISS1R (0.53) KISS1RHTR2AHRH1
SCHEMBL13366903 0.86 KISS1R (0.53) KISS1RHTR2AHRH1
SCHEMBL10026152 0.85 KISS1R (0.47) KISS1RHTR2AHRH1
SCHEMBL9976417 0.85 KISS1R (0.47) KISS1RHTR2AHRH1
SCHEMBL14525109 0.85 KISS1R (0.47) KISS1RHTR2AHRH1
SCHEMBL16316765 0.84 KISS1R (0.33) KISS1RHTR2AHRH1
SCHEMBL23946773 0.83 KISS1R (0.46) KISS1R
SCHEMBL13035660 0.82 KISS1R (0.32) KISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230366018-A1 LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2023-11-16 US disclosed
US-20230366018-A1 LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2023-11-16 US disclosed
WO-2023116911-A1 ANTI-FRα ANTIBODY, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOF 百奥泰生物制药股份有限公司 2023-06-29 WO disclosed
WO-2023061457-A1 ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOF 百奥泰生物制药股份有限公司 2023-04-20 WO disclosed
US-20220396702-A1 PROTECTED DYE-LABELED REAGENTS PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2022-12-15 US disclosed
US-11466319-B2 Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2022-10-11 US disclosed
US-11359235-B2 Modified nucleotide reagents PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2022-06-14 US disclosed
US-11203689-B2 Protected dye-labeled reagents PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2021-12-21 US disclosed
US-20210147928-A1 LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2021-05-20 US disclosed
US-10800805-B2 Protected fluorescent reagent compounds PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2020-10-13 US disclosed
US-9957291-B2 Protected fluorescent reagent compounds PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2018-05-01 US disclosed
US-20180072775-A1 Beta-Hairpin Peptidomimetics POLYPHOR AG (CH) 2018-03-15 US disclosed
US-20170321268-A1 MODIFIED NUCLEOTIDE REAGENTS PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2017-11-09 US disclosed
US-20170145502-A1 MODIFIED NUCLEOTIDE REAGENTS PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2017-05-25 US disclosed
US-20170145496-A1 LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2017-05-25 US disclosed
US-20170145495-A1 PROTECTED DYE-LABELED REAGENTS PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2017-05-25 US disclosed
US-20160237279-A1 MULTIMERIC PROTECTED FLUORESCENT REAGENTS PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2016-08-18 US disclosed
WO-2016126941-A1 MULTIMERIC PROTECTED FLUORESCENT REAGENTS PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2016-08-11 WO disclosed
US-20150050659-A1 PROTECTED FLUORESCENT REAGENT COMPOUNDS PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 2015-02-19 US disclosed
WO-2015021079-A1 PROTECTED FLUORESCENT REAGENT COMPOUNDS PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) 2015-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11359235-B2 Modified nucleotide reagents POLL, POLN, POLM KISS1R 4123/4885HTR2A 2460/4885HRH1 4762/4885
US-20170321268-A1 MODIFIED NUCLEOTIDE REAGENTS POLL, POLN, POLM KISS1R 4123/4885HTR2A 2460/4885HRH1 4762/4885
US-20150050659-A1 PROTECTED FLUORESCENT REAGENT COMPOUNDS ERCC4, ERCC2, ERCC1 KISS1R 3717/4885HTR2A 3539/4885HRH1 3407/4885
US-20220396702-A1 PROTECTED DYE-LABELED REAGENTS POLL, POLB, POLM KISS1R 4271/4885HTR2A 2134/4885HRH1 4750/4885
US-20170145495-A1 PROTECTED DYE-LABELED REAGENTS POLL, POLB, POLM KISS1R 4271/4885HTR2A 2134/4885HRH1 4750/4885
US-10800805-B2 Protected fluorescent reagent compounds ERCC4, ERCC2, ERCC1 KISS1R 3717/4885HTR2A 3539/4885HRH1 3407/4885
US-20170145496-A1 LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING POLL, POLN, POLB KISS1R 3480/4885HTR2A 1785/4885HRH1 4751/4885
US-20210147928-A1 LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING POLL, POLN, POLB KISS1R 3480/4885HTR2A 1785/4885HRH1 4751/4885
US-11466319-B2 Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing POLL, POLN, POLB KISS1R 3480/4885HTR2A 1785/4885HRH1 4751/4885
US-20230366018-A1 LABELED NUCLEOTIDE ANALOGS, REACTION MIXTURES, AND METHODS AND SYSTEMS FOR SEQUENCING POLL, POLN, POLB KISS1R 3480/4885HTR2A 1785/4885HRH1 4751/4885
US-11203689-B2 Protected dye-labeled reagents POLL, POLB, POLM KISS1R 4271/4885HTR2A 2134/4885HRH1 4750/4885
US-20180072775-A1 Beta-Hairpin Peptidomimetics POLQ, POLL, POLM KISS1R 2224/4885HTR2A 4753/4885HRH1 393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.